2-Hydroxy-4-Methoxybenzophenone-5-Sulfonic Acid

We are 2-Hydroxy-4-Methoxybenzophenone-5-Sulfonic Acid CAS:4065-45-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 2-Hydroxy-4-Methoxybenzophenone-5-Sulfonic Acid
Other Name: Sulisobenzone;Sulisobenzone Hydrate;5-Benzoyl-4-hydroxy-2-methoxybenzenesulfonic acid
CAS No: 4065-45-6
MF: C14H12O6S
MW: 308.30600
Density: 1.4±0.1 g/cm3
Boiling point: 0°C
Melting point: 170 °C
Flash point: 0°C
Refractive index: 1.617
UN Number: N.A
UN Proper Shipping Name: N.A
Transport hazard class: N.A
Packing group: N.A
 
Specification
Appearance: White or light yellow crystalline powder
Assay: ≥99%
Loss on drying: ≤3.0%
Heavy metal: ≤5ppm
Hazen: ≤2.0
Turbidity: ≤4.0 EBC
 
Application
It is an excellent water-soluble UV absorber. 
It is mainly used as an anti-suning agent and sunscreen agent in water-soluble cosmetics. 
It can also be used as a UV absorber in other water-soluble inks and coatings.
It is an ingredient in some sunscreens which protects the skin from damage by UVB and short-wave UVA ultraviolet light.
Widely used in cosmetics such as sunscreen cream, cream, honey, lotion, oil, etc.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2-Hydroxy-4-Methoxybenzophenone-5-Sulfonic Acid


Related News: Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.5-Cyano-2-fluoropyridine Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.(9,9-dimethylfluoren-2-yl)boronic acid CAS:333432-28-3 Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.4- (4-bromofenil) -6-fenildibenzo [b, d] furano CAS:1556069-46-5 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.

Related Products
Product Name
5-trityl-4,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2-one View Details
N-[[dimethoxy(methyl)silyl]oxymethyl]aniline View Details
1,4-difluorobenzene View Details
9-(4-Bromophenyl)carbazole manufacturer Pentapeptide-31 manufacturer 5-Bromo-2-Hydroxy-3-Picoline manufacturer Methyl 2,3-dibromopropionate manufacturer 4-tert-Butylphenylboronic acid manufacturer